OKYO Pharma OKYO
NASDAQ OKYO
$1.32 +0.02 (+1.54%)
As of: Oct 1, 2026 · 2:12 PM EDT

OKYO Pharma (OKYO) Cash from Financing Activities (2025 - 2026)

Updated

OKYO Pharma (OKYO) reported Cash from Financing Activities of $22.37 million for the quarter ended Mar 31, 2026.

Analysis

OKYO Pharma (OKYO) Cash from Financing Activities (2025 - 2026) Analysis & Trends

For the year ended Mar 31, 2026, OKYO Pharma posted Cash from Financing Activities of $25.02 million, up 842.2% from the prior year.

  • Cash from Financing Activities has a five-year compound annual growth rate of 26.2% (years ended Mar 2021 to Mar 2026).
  • By year, Cash from Financing Activities came in at $2.66 million in the year ended Mar 31, 2025, $6.21 million in the year ended Dec 31, 2024 (-33.4%), $9.32 million in the year ended Dec 31, 2023 and $2.15 million in the year ended Mar 31, 2022 (-72.5%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -8.78 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -5.05 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.76 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -2.02 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -47.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -1.48 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 2.34 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -3.66 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -426.70 Mn
10 OKYO Pharma 867.87 Mn 867.87 Mn - 22.37 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 22.37 Mn
Dec 31, 2025 -1.66 Mn
API Access

OKYO Pharma Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=OKYO&period=max&api_key=YOUR_API_KEY